BACKGROUND AND PURPOSE: In preclinical stroke models, high-dose human albumin confers robust neuroprotection. We investigated the safety and tolerability of this therapy in patients with acute ischemic stroke.

• 背景及目的：在临床前的动物中风模型中，高剂量的人血清白蛋白显示出明显的神经保护作用。本文研究了人血清白蛋白治疗急性缺血性中风的耐受性及安全性。